BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.810
-0.070 (-2.43%)
Jun 18, 2025, 9:39 AM - Market open
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $5.05 million as of June 18, 2025. Its market cap has decreased by -32.73% in one year.
Market Cap
5.05M
Enterprise Value
1.80M
1-Year Change
-32.73%
Ranking
Category
Stock Price
$2.81
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $5.05M, a decrease of -88.01%. That is a compound annual growth rate of -36.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2025 | 5.17M | 2.96% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 220.04B |
| BHP Group | 123.72B |
| Rio Tinto Group | 98.78B |
| The Sherwin-Williams Company | 84.36B |
| Southern Copper | 77.58B |
| Ecolab | 75.57B |
| Newmont | 64.87B |
| Air Products and Chemicals | 62.65B |